L-カルニチンは肝切除患者のアンモニア代謝を改善する
基本情報
- NCT ID
- NCT03021876
- ステータス
- 不明
- 試験のフェーズ
- 第2/第3相
- 試験タイプ
- 介入
- 目標被験者数
- 80
- 治験依頼者名
- Kochi University
概要
L-carnitine is synthesized from lysine and methionine. Postmortem concentrations of carnitine in liver, muscle, heart, kidney, and brain averaged only one-fourth to one-third those in corresponding tissues of eight normally nourished non-hepatic patients who died after an acute illness of a 1-3-day duration. In the recent years, it has been reported that sirtuin 3 (SIRT3) is protective against acute kidney injury (AKI) and suggest that enhancing SIRT3 to improve mitochondrial dynamics has potential as a strategy for improving outcomes of renal injury. In the current study, it is the first clinical interventional research whether L-carnitine corrects ammonia metabolism associated with liver injury in hepatectomized patients.
対象疾患
介入
依頼者(Sponsor)
実施施設 (1)
高知県・高知市病院企業団立高知医療センター
Kochi, Kochi, Japan(RECRUITING)